Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser light may fade scars after major body surgery

NCT ID NCT07359352

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether early treatment with ProFractional laser and Broadband Light (BBL) can improve the look and feel of scars after body-contouring surgeries like tummy tucks or arm lifts. About 150 adults will take part, with some receiving up to three laser sessions and others getting standard care. Researchers will check scar appearance and symptoms using patient surveys and photos over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ProFractional laser and Broadband Light (BBL) therapy
What this could lead to
If it works, this could offer a way to make surgical scars look better and feel less itchy or painful.
What could go wrong
This is a small, early study at one center. The treatment may not improve scars for everyone, and laser therapy can cause temporary redness or swelling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 18 years or older. Scheduled to undergo one or more of the following major body-contouring procedures during the study period: Brachioplasty (arm lift) Chest or breast contouring surgery Abdominoplasty or panniculectomy Buttock lift or lower body lift Thighplasty (thigh lift) Able and willing to provide written informed consent. Able to read and write in English (required for completion of validated questionnaires). Willing and able to comply with scheduled follow-up visits, questionnaires, and study procedures for up to 12 months post-surgery. Exclusion Criteria: Inability or unwillingness to provide informed consent. Inability to comply with study visits or procedures. Non-English speakers, as the validated SCAR-Q and POSAS instruments are not currently available in equivalent translations. Current use of nicotine or nicotine-containing products, including cigarettes, vaping, chewing tobacco, or nicotine replacement therapy, due to the known adverse effects of nicotine on wound healing and scar formation. Any medical condition, treatment, or circumstance that, in the opinion of the Investigator, may increase participant risk, compromise safety, or interfere with study participation or data integrity. Pregnant or breastfeeding women (laser/BBL therapy contraindicated in pregnancy). History of abnormal scar formation such as keloids or hypertrophic scarring (if deemed clinically significant by the investigator). Recent energy-based treatment (laser, IPL, or BBL) to the surgical site within the previous 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aesthetic surgical outcomes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cicatrix, Hypertrophic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.